Skip to main navigation Skip to search Skip to main content

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

  • Paul G. Richardson
  • , Wanling Xie
  • , Sundar Jagannath
  • , Andrzej Jakubowiak
  • , Sagar Lonial
  • , Noopur S. Raje
  • , Melissa Alsina
  • , Irene M. Ghobrial
  • , Robert L. Schlossman
  • , Nikhil C. Munshi
  • , Amitabha Mazumder
  • , David H. Vesole
  • , Jonathan L. Kaufman
  • , Kathleen Colson
  • , Mary McKenney
  • , Laura E. Lunde
  • , John Feather
  • , Michelle E. Maglio
  • , Diane Warren
  • , Dixil Francis
    • Teru Hideshima, Robert Knight, Dixie Lee Esseltine, Constantine S. Mitsiades, Edie Weller, Kenneth C. Anderson

Research output: Contribution to journal › Article › peer-review

178 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science